Cassava Sciences Inc (NASDAQ:SAVA) has a beta value of -0.94 and has seen 1.31 million shares traded in the recent trading session. The company, currently valued at $146.73M, closed the recent trade at $3.05 per share which meant it gained $0.11 on the day or 3.74% during that session. The SAVA stock price is -1283.61% off its 52-week high price of $42.20 and 26.89% above the 52-week low of $2.23. If we look at the company’s 10-day average daily trading volume, we find that it stood at 4.29 million shares traded. The 3-month trading volume is 5.51 million shares.
The consensus among analysts is that Cassava Sciences Inc (SAVA) is Hold stock at the moment, with a recommendation rating of 3.67. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 2 out of 2 have rated it as a Hold, with 0 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.68.
Cassava Sciences Inc (NASDAQ:SAVA) trade information
Sporting 3.74% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the SAVA stock price touched $3.05 or saw a rise of 4.09%. Year-to-date, Cassava Sciences Inc shares have moved 29.24%, while the 5-day performance has seen it change 27.08%. Over the past 30 days, the shares of Cassava Sciences Inc (NASDAQ:SAVA) have changed -0.33%. Short interest in the company has seen 17.62 million shares shorted with days to cover at 1.56.
Cassava Sciences Inc (SAVA) estimates and forecasts
Figures show that Cassava Sciences Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -73.59% over the past 6 months, with this year growth rate of 31.90%, compared to 16.70% for the industry. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -30.45% over the past 5 years.
SAVA Dividends
Cassava Sciences Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Cassava Sciences Inc (NASDAQ:SAVA)’s Major holders
Insiders own 12.65% of the company shares, while shares held by institutions stand at 29.93% with a share float percentage of 34.27%. Investors are also buoyed by the number of investors in a company, with Cassava Sciences Inc having a total of 225.0 institutions that hold shares in the company. The top two institutional holders are BLACKROCK INC. with over 3.22 million shares worth more than $39.76 million. As of 2024-06-30, BLACKROCK INC. held 7.4874% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 2.68 million shares as of 2024-06-30. The firm’s total holdings are worth over $33.14 million and represent 6.2397% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF . As of Sep 30, 2024 , the former fund manager holds about 2.65% shares in the company for having 1.28 shares of worth $3.85 million while later fund manager owns 1.05 shares of worth $3.16 million as of Oct 31, 2024 , which makes it owner of about 2.17% of company’s outstanding stock.
